These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29855807)

  • 21. Environment-responsive multifunctional liposomes.
    Kale AA; Torchilin VP
    Methods Mol Biol; 2010; 605():213-42. PubMed ID: 20072884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pH-sensitive stearoyl-PEG-poly(methacryloyl sulfadimethoxine)-decorated liposome system for protein delivery: An application for bladder cancer treatment.
    Vila-Caballer M; Codolo G; Munari F; Malfanti A; Fassan M; Rugge M; Balasso A; de Bernard M; Salmaso S
    J Control Release; 2016 Sep; 238():31-42. PubMed ID: 27444816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Switchable Lipids: Conformational Change for Fast pH-Triggered Cytoplasmic Delivery.
    Viricel W; Mbarek A; Leblond J
    Angew Chem Int Ed Engl; 2015 Oct; 54(43):12743-7. PubMed ID: 26189870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pyridylhydrazone-based PEGylation for pH-reversible lipopolyplex shielding.
    Nie Y; Günther M; Gu Z; Wagner E
    Biomaterials; 2011 Jan; 32(3):858-69. PubMed ID: 21030074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formulation, characterization and tissue distribution of a novel pH-sensitive long-circulating liposome-based theranostic suitable for molecular imaging and drug delivery.
    Duan Y; Wei L; Petryk J; Ruddy TD
    Int J Nanomedicine; 2016; 11():5697-5708. PubMed ID: 27843312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gemcitabine-loaded Folic Acid Tagged Liposomes: Improved Pharmacokinetic and Biodistribution Profile.
    Unnam S; Panduragaiah VM; Sidramappa MA; Muddana Eswara BR
    Curr Drug Deliv; 2019; 16(2):111-122. PubMed ID: 30360740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of lipid composition and preparation conditions on physical-chemical properties, technological parameters and in vitro biological activity of gemcitabine-loaded liposomes.
    Calvagno MG; Celia C; Paolino D; Cosco D; Iannone M; Castelli F; Doldo P; Frest M
    Curr Drug Deliv; 2007 Jan; 4(1):89-101. PubMed ID: 17269921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Esterase-catalyzed dePEGylation of pH-sensitive vesicles modified with cleavable PEG-lipid derivatives.
    Xu H; Deng Y; Chen D; Hong W; Lu Y; Dong X
    J Control Release; 2008 Sep; 130(3):238-45. PubMed ID: 18657874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of high-content gemcitabine PEGylated liposomes and their cytotoxicity on drug-resistant pancreatic tumour cells.
    Xu H; Paxton J; Lim J; Li Y; Zhang W; Duxfield L; Wu Z
    Pharm Res; 2014 Oct; 31(10):2583-92. PubMed ID: 24639234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of cleavable PEG-cholesterol derivatives on the accelerated blood clearance of PEGylated liposomes.
    Xu H; Wang KQ; Deng YH; Chen DW
    Biomaterials; 2010 Jun; 31(17):4757-63. PubMed ID: 20303164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of the molecular weight and molar ratio of poly(2-ethyl-2-oxazoline)-based lipid on the pH sensitivity, stability, and antitumor efficacy of liposomes.
    Wen L; Huang S; Du W; Zhu C; Xu H
    Drug Dev Ind Pharm; 2020 Feb; 46(2):283-295. PubMed ID: 31944130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancing siRNA-based cancer therapy using a new pH-responsive activatable cell-penetrating peptide-modified liposomal system.
    Xiang B; Jia XL; Qi JL; Yang LP; Sun WH; Yan X; Yang SK; Cao DY; Du Q; Qi XR
    Int J Nanomedicine; 2017; 12():2385-2405. PubMed ID: 28405163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo activity of gemcitabine-loaded PEGylated small unilamellar liposomes against pancreatic cancer.
    Cosco D; Bulotta A; Ventura M; Celia C; Calimeri T; Perri G; Paolino D; Costa N; Neri P; Tagliaferri P; Tassone P; Fresta M
    Cancer Chemother Pharmacol; 2009 Oct; 64(5):1009-20. PubMed ID: 19263052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NGR-modified pH-sensitive liposomes for controlled release and tumor target delivery of docetaxel.
    Gu Z; Chang M; Fan Y; Shi Y; Lin G
    Colloids Surf B Biointerfaces; 2017 Dec; 160():395-405. PubMed ID: 28965079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ["PEG dilemma" for liposomes and its solving approaches].
    Zhang D; Xu H; Hu MN; Deng YH
    Yao Xue Xue Bao; 2015 Mar; 50(3):252-60. PubMed ID: 26118102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. pH-Sensitive PEGylated Liposomal Silybin: Synthesis, In Vitro and In Vivo Anti-Tumor Evaluation.
    Gheybi F; Alavizadeh SH; Rezayat SM; Hatamipour M; Akhtari J; Faridi Majidi R; Badiee A; Jaafari MR
    J Pharm Sci; 2021 Dec; 110(12):3919-3928. PubMed ID: 34418455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor microenvironment responsive VEGF-antibody functionalized pH sensitive liposomes of docetaxel for augmented breast cancer therapy.
    Jain S; Deore SV; Ghadi R; Chaudhari D; Kuche K; Katiyar SS
    Mater Sci Eng C Mater Biol Appl; 2021 Feb; 121():111832. PubMed ID: 33579470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Folate-Conjugated pH-Responsive Nanocarrier Designed for Active Tumor Targeting and Controlled Release of Gemcitabine.
    Pourjavadi A; Tehrani ZM; Moghanaki AA
    Pharm Res; 2016 Feb; 33(2):417-32. PubMed ID: 26438181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and In Vitro Evaluation of Long Circulating Liposomes for Targeted Delivery of Gemcitabine and Irinotecan in Pancreatic Ductal Adenocarcinoma.
    Deodhar S; Dash AK; North EJ; Hulce M
    AAPS PharmSciTech; 2020 Aug; 21(6):231. PubMed ID: 32778980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of a novel pH-sensitive liposome with cleavable esterase-catalyzed and pH-responsive double smart mPEG lipid derivative on ABC phenomenon.
    Chen D; Liu W; Shen Y; Mu H; Zhang Y; Liang R; Wang A; Sun K; Fu F
    Int J Nanomedicine; 2011; 6():2053-61. PubMed ID: 21976980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.